SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations - PubMed (original) (raw)
Review
. 2017 Feb;173(2):327-337.
doi: 10.1002/ajmg.a.38022. Epub 2016 Oct 24.
Affiliations
- PMID: 27774744
- PMCID: PMC5297989
- DOI: 10.1002/ajmg.a.38022
Review
SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations
Yuri A Zarate et al. Am J Med Genet A. 2017 Feb.
Abstract
The SATB2-associated syndrome is a recently described syndrome characterized by developmental delay/intellectual disability with absent or limited speech development, craniofacial abnormalities, behavioral problems, dysmorphic features, and palatal and dental abnormalities. Alterations of the SATB2 gene can result from a variety of different mechanisms that include contiguous deletions, intragenic deletions and duplications, translocations with secondary gene disruption, and point mutations. The multisystemic nature of this syndrome demands a multisystemic approach and we propose evaluation and management guidelines. The SATB2-associated syndrome registry has now been started and that will allow gathering further clinical information and refining the provided surveillance recommendations. © 2016 The Authors. American Journal of Medical Genetics Part A Published by Wiley Periodicals, Inc.
Keywords: 2q32 deletion syndrome; 2q33.1 microdeletion syndrome; Glass syndrome; SATB2; SATB2-associated syndrome.
© 2016 The Authors. American Journal of Medical Genetics Part A Published by Wiley Periodicals, Inc.
Figures
Figure 1
UCSC Genome Browser (GRCh37/hg19) assembly depiction of published deletions encompassing SATB2 included in this review. Deletions are represented in red while duplications are represented in blue. [Color figure can be viewed at
wileyonlinelibrary.com
].
Figure 2
A. Schematic diagram of the SATB2 protein according to Uniprot and Pfam with location of point mutations depicted with arrows. In addition to the two CUT domains (CUT1 and CUT2) and a homeodomain (HOX), the SATB, ubiquitin‐like oligomerization domain (ULD) and the SATB, CUT1‐like DNA‐binding domain (CUTL) are depicted. B. Presence (+) or absence (−) of the main clinical features for those point mutations represented in A. Blank spaces represent no information provided for the given feature. aNM_001172517, accessed June 2016; bNM_15265, accessed June 2016; cNM_001172509, accessed June 2016. [Color figure can be viewed at
wileyonlinelibrary.com
].
Similar articles
- Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome.
Rosenfeld JA, Ballif BC, Lucas A, Spence EJ, Powell C, Aylsworth AS, Torchia BA, Shaffer LG. Rosenfeld JA, et al. PLoS One. 2009 Aug 10;4(8):e6568. doi: 10.1371/journal.pone.0006568. PLoS One. 2009. PMID: 19668335 Free PMC article. - SATB2-associated syndrome in patients from Japan: Linguistic profiles.
Yamada M, Uehara T, Suzuki H, Takenouchi T, Yoshihashi H, Suzumura H, Mizuno S, Kosaki K. Yamada M, et al. Am J Med Genet A. 2019 Jun;179(6):896-899. doi: 10.1002/ajmg.a.61114. Epub 2019 Mar 7. Am J Med Genet A. 2019. PMID: 30848049 - Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing.
Zarate YA, Perry H, Ben-Omran T, Sellars EA, Stein Q, Almureikhi M, Simmons K, Klein O, Fish J, Feingold M, Douglas J, Kruer MC, Si Y, Mao R, McKnight D, Gibellini F, Retterer K, Slavotinek A. Zarate YA, et al. Am J Med Genet A. 2015 May;167A(5):1026-32. doi: 10.1002/ajmg.a.36849. Am J Med Genet A. 2015. PMID: 25885067 - Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2.
Zarate YA, Bosanko KA, Thomas MA, Miller DT, Cusmano-Ozog K, Martinez-Monseny A, Curry CJ, Graham JM Jr, Velsher L, Bekheirnia MR, Seidel V, Dedousis D, Mitchell AL, DiMarino AM, Riess A, Balasubramanian M, Fish JL, Caffrey AR, Fleischer N, Pierson TM, Lacro RV. Zarate YA, et al. Clin Genet. 2021 Apr;99(4):547-557. doi: 10.1111/cge.13912. Epub 2021 Jan 13. Clin Genet. 2021. PMID: 33381861 Review. - _SATB2_-Associated Syndrome Due to a c.715C>T:p(Arg239*) Variant in Adulthood: Natural History and Literature Review.
Copelli MM, Pairet E, Atique-Tacla M, Vieira TP, Appenzeller S, Helaers R, Vikkula M, Gil-da-Silva-Lopes VL. Copelli MM, et al. Genes (Basel). 2023 Apr 8;14(4):882. doi: 10.3390/genes14040882. Genes (Basel). 2023. PMID: 37107640 Free PMC article. Review.
Cited by
- A novel mutation of SATB2 inhibits odontogenesis of human dental pulp stem cells through Wnt/β-catenin signaling pathway.
Xin T, Li Q, Bai R, Zhang T, Zhou Y, Zhang Y, Han B, Yang R. Xin T, et al. Stem Cell Res Ther. 2021 Dec 4;12(1):595. doi: 10.1186/s13287-021-02660-8. Stem Cell Res Ther. 2021. PMID: 34863303 Free PMC article. - SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance.
Fazio M, van Rooijen E, Dang M, van de Hoek G, Ablain J, Mito JK, Yang S, Thomas A, Michael J, Fabo T, Modhurima R, Pessina P, Kaufman CK, Zhou Y, White RM, Zon LI. Fazio M, et al. Elife. 2021 Feb 2;10:e64370. doi: 10.7554/eLife.64370. Elife. 2021. PMID: 33527896 Free PMC article. - The _cis_-regulatory effects of modern human-specific variants.
Weiss CV, Harshman L, Inoue F, Fraser HB, Petrov DA, Ahituv N, Gokhman D. Weiss CV, et al. Elife. 2021 Apr 22;10:e63713. doi: 10.7554/eLife.63713. Elife. 2021. PMID: 33885362 Free PMC article. - The behavioural phenotype of SATB2-associated syndrome: a within-group and cross-syndrome analysis.
Bissell S, Oliver C, Moss J, Heald M, Waite J, Crawford H, Kothari V, Rumbellow L, Walters G, Richards C. Bissell S, et al. J Neurodev Disord. 2022 Mar 29;14(1):25. doi: 10.1186/s11689-022-09426-0. J Neurodev Disord. 2022. PMID: 35350986 Free PMC article. - SATB2-associated syndrome: characterization of skeletal features and of bone fragility in a prospective cohort of 19 patients.
Mouillé M, Rio M, Breton S, Piketty ML, Afenjar A, Amiel J, Capri Y, Goldenberg A, Francannet C, Michot C, Mignot C, Perrin L, Quelin C, Van Gils J, Barcia G, Pingault V, Maruani G, Koumakis E, Cormier-Daire V. Mouillé M, et al. Orphanet J Rare Dis. 2022 Mar 3;17(1):100. doi: 10.1186/s13023-022-02229-5. Orphanet J Rare Dis. 2022. PMID: 35241104 Free PMC article.
References
- Alcamo EA, Chirivella L, Dautzenberg M, Dobreva G, Farinas I, Grosschedl R, McConnell SK. 2008. Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57:364–377. - PubMed
- Asadollahi R, Oneda B, Joset P, Azzarello‐Burri S, Bartholdi D, Steindl K, Vincent M, Cobilanschi J, Sticht H, Baldinger R, Reissmann R, Sudholt I, Thiel CT, Ekici AB, Reis A, Bijlsma EK, Andrieux J, Dieux A, FitzPatrick D, Ritter S, Baumer A, Latal B, Plecko B, Jenni OG, Rauch A. 2014. The clinical significance of small copy number variants in neurodevelopmental disorders. J Med Genet 51:677–688. - PMC - PubMed
- Balasubramanian M, Smith K, Basel‐Vanagaite L, Feingold MF, Brock P, Gowans GC, Vasudevan PC, Cresswell L, Taylor EJ, Harris CJ, Friedman N, Moran R, Feret H, Zackai EH, Theisen A, Rosenfeld JA, Parker MJ. 2011. Case series: 2q33.1 microdeletion syndrome‐further delineation of the phenotype. J Med Genet 48:290–298. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical